DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma: A phase 3 randomised trial. The DREAM3R trial

被引：0

作者：

John, Thomas ^{[1
]}

Forde, Patrick ^{[2
]}

Kok, Peey Sei ^{[3
]}

Brown, Chris ^{[3
]}

Sun, Zhuoxin ^{[4
]}

O'Byrne, Kenneth ^{[5
,6
]}

Yip, Sonia ^{[3
]}

Anagnostou, Valasamo ^{[7
]}

Cook, Alistair ^{[8
,9
]}

Lesterhuis, Willem J. ^{[8
]}

Hughes, Brett G. M. ^{[10
,11
]}

Johnson, Lisa ^{[12
]}

Oostendorp, Martijn ^{[3
]}

Marinucci, Donna ^{[12
]}

Fitzpatrick, Karen ^{[12
]}

Ford, Kate ^{[3
]}

Pavlakis, Nick ^{[13
,14
]}

Brahmer, Julie ^{[2
]}

Stockler, Martin R. ^{[3
]}

Ramalingam, Suresh ^{[15
]}

Nowak, Anna ^{[8
,9
,16
]}

机构：

[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[2] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[3] Univ Sydney, Nhmrc Clin Trials Ctr, Camperdown, NSW, Australia

[4] IBCSG Stat Ctr, Boston, MA USA

[5] Princess Alexandra Hosp, Brisbane, Qld, Australia

[6] Queensland Univ Technol, Brisbane, Qld, Australia

[7] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA

[8] Univ Western Australia, Natl Ctr Asbestos Related Dis, Perth, WA, Australia

[9] Univ Western Australia, Med Sch, Perth, WA, Australia

[10] Prince Charles Hosp, Canc Care Serv, Brisbane, Qld, Australia

[11] Univ Queensland, Brisbane, Qld, Australia

[12] PrECOG, Philadelphia, PA USA

[13] Northern Canc Inst, Sydney, NSW, Australia

[14] Univ Sydney, Sydney, NSW, Australia

[15] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

[16] Sir Charles Gairdner Hosp, Med Oncol, Perth, WA, Australia

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

404

引用

页码：205 / 206

页数：2

共 50 条

[21] A Multicenter, Randomized, Phase 3 Trial of Penpulimab in Combination With Anlotinib or Chemotherapy as First-Line Treatment in Advanced NSCLC
Han, B.
Chen, J.
Xie, Q.
Yao, W.
Shi, H.
Zhao, Y.
Song, W.
Jin, X.
Wang, Z.
Li, B.
Xia, Y.
Jiao, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S650 - S650
[22] First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Baas, Paul
Scherpereel, Arnaud
Nowak, Anna K.
Fujimoto, Nobukazu
Peters, Solange
Tsao, Anne S.
Mansfield, Aaron S.
Popat, Sanjay
Jahan, Thierry
Antonia, Scott
Oulkhouir, Youssef
Bautista, Yolanda
Cornelissen, Robin
Greillier, Laurent
Grossi, Francesco
Kowalski, Dariusz
Rodriguez-Cid, Jeronimo
Aanur, Praveen
Oukessou, Abderrahim
Baudelet, Christine
Zalcman, Gerard
LANCET, 2021, 397 (10272): : 375 - 386
[23] Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
Fennell, Dean A.
McDowell, Cliona
Busacca, Sara
Webb, Glen
Moulton, Brian
Cakana, Andrew
O'Byrne, Kenneth J.
Meerbeeck, Jan V.
Donnellan, Paul
McCaffrey, John
Baas, Paul
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1466 - 1470
[24] STELLAR Trial: Radiological Response Patterns of TTFields Plus Chemotherapy in First-Line Treatment of Malignant Pleural Mesothelioma
Grosso, F.
Aerts, J.
Ramlau, R.
Cedres, S.
Mencoboni, M.
Van Meerbeeck, J.
Dziadziuszko, R.
Planchard, D.
Chella, A.
Crino, L.
Krzakowski, M.
Ceresoli, G. L.
Weinberg, U.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S755 - S755
[25] STELLAR - Interim Results of a Phase 2 Trial of TTFields with Chemotherapy for First Line Treatment of Malignant Mesothelioma
Grosso, Federica
Madrzak, Jarek
Ramlau, Rodryg
Cedres Perez, Susana
Crino, Lucio
Chella, Antonio
Mencoboni, Manlio
Hiddinga, Birgitta
Ceresoli, Giovanni
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S329 - S329
[26] Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Hai-Qiang Mai
Qiu-Yan Chen
Dongping Chen
Chaosu Hu
Kunyu Yang
Jiyu Wen
Jingao Li
Ying-Rui Shi
Feng Jin
Ruilian Xu
Jianji Pan
Shenhong Qu
Ping Li
Chunhong Hu
Yi-Chun Liu
Yi Jiang
Xia He
Hung-Ming Wang
Wan-Teck Lim
Wangjun Liao
Xiaohui He
Xiaozhong Chen
Zhigang Liu
Xianglin Yuan
Qi Li
Xiaoyan Lin
Shanghua Jing
Yanju Chen
Yin Lu
Ching-Yun Hsieh
Muh-Hwa Yang
Chia-Jui Yen
Jens Samol
Hui Feng
Sheng Yao
Patricia Keegan
Rui-Hua Xu
Nature Medicine, 2021, 27 : 1536 - 1543
[27] Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Mai, Hai-Qiang
Chen, Qiu-Yan
Chen, Dongping
Hu, Chaosu
Yang, Kunyu
Wen, Jiyu
Li, Jingao
Shi, Ying-Rui
Jin, Feng
Xu, Ruilian
Pan, Jianji
Qu, Shenhong
Li, Ping
Hu, Chunhong
Liu, Yi-Chun
Jiang, Yi
He, Xia
Wang, Hung-Ming
Lim, Wan-Teck
Liao, Wangjun
He, Xiaohui
Chen, Xiaozhong
Liu, Zhigang
Yuan, Xianglin
Li, Qi
Lin, Xiaoyan
Jing, Shanghua
Chen, Yanju
Lu, Yin
Hsieh, Ching-Yun
Yang, Muh-Hwa
Yen, Chia-Jui
Samol, Jens
Feng, Hui
Yao, Sheng
Keegan, Patricia
Xu, Rui-Hua
NATURE MEDICINE, 2021, 27 (09) : 1536 - +
[28] Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Maughan, Timothy S.
Adams, Richard A.
Smith, Christopher G.
Meade, Angela M.
Seymour, Matthew T.
Wilson, Richard H.
Idziaszczyk, Shelley
Harris, Rebecca
Fisher, David
Kenny, Sarah L.
Kay, Edward
Mitchell, Jenna K.
Madi, Ayman
Jasani, Bharat
James, Michelle D.
Bridgewater, John
Kennedy, M. John
Claes, Bart
Lambrechts, Diether
Kaplan, Richard
Cheadle, Jeremy P.
LANCET, 2011, 377 (9783): : 2103 - 2114
[29] Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Adams, Richard A.
Meade, Angela M.
Seymour, Matthew T.
Wilson, Richard H.
Madi, Ayman
Fisher, David
Kenny, Sarah L.
Kay, Edward
Hodgkinson, Elizabeth
Pope, Malcolm
Rogers, Penny
Wasan, Harpreet
Falk, Stephen
Gollins, Simon
Hickish, Tamas
Bessell, Eric M.
Propper, David
Kennedy, M. John
Kaplan, Richard
Maughan, Timothy S.
LANCET ONCOLOGY, 2011, 12 (07): : 642 - 653
[30] Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
Fennell, DA
Steele, JPC
Shamash, J
Sheaff, MT
Evans, MT
Goonewardene, TI
Nystrom, ML
Gower, NH
Rudd, RM
LUNG CANCER, 2005, 47 (02) : 277 - 281

← 1 2 3 4 5 →